Cargando…

Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma

BACKGROUND: Cancer stem cells (CSCs) are widely thought to contribute to the dismal prognosis of pancreatic ductal adenocarcinoma (PDAC). CSCs share biological features with adult stem cells, such as longevity, self-renewal capacity, differentiation, drug resistance, and the requirement for a niche;...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Rong, Liu, Xiaomeng, Wang, Wei, Hua, Jie, Xu, Jin, Liang, Chen, Meng, Qingcai, Liu, Jiang, Zhang, Bo, Yu, Xianjun, Shi, Si
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071957/
https://www.ncbi.nlm.nih.gov/pubmed/33912458
http://dx.doi.org/10.3389/fonc.2021.643465
_version_ 1783683818953113600
author Tang, Rong
Liu, Xiaomeng
Wang, Wei
Hua, Jie
Xu, Jin
Liang, Chen
Meng, Qingcai
Liu, Jiang
Zhang, Bo
Yu, Xianjun
Shi, Si
author_facet Tang, Rong
Liu, Xiaomeng
Wang, Wei
Hua, Jie
Xu, Jin
Liang, Chen
Meng, Qingcai
Liu, Jiang
Zhang, Bo
Yu, Xianjun
Shi, Si
author_sort Tang, Rong
collection PubMed
description BACKGROUND: Cancer stem cells (CSCs) are widely thought to contribute to the dismal prognosis of pancreatic ductal adenocarcinoma (PDAC). CSCs share biological features with adult stem cells, such as longevity, self-renewal capacity, differentiation, drug resistance, and the requirement for a niche; these features play a decisive role in cancer progression. A prominent characteristic of PDAC is metabolic reprogramming, which provides sufficient nutrients to support rapid tumor cell growth. However, whether PDAC stemness is correlated with metabolic reprogramming remains unknown. METHOD: RNA sequencing data of PDAC, including read counts and fragments per kilobase of transcript per million mapped reads (FPKM), were collected from The Cancer Genome Atlas-Pancreatic Adenocarcinoma (TCGA-PAAD) database. Single-sample gene set enrichment analysis (GSEA) was used to calculate the relative activities of metabolic pathways in each PDAC sample. Quantitative real-time PCR was performed to validate the expression levels of genes of interest. RESULTS: The overall survival (OS) of patients with high mRNA expression-based stemness index (mRNAsi) values was significantly worse than that of their counterparts with low mRNAsi values (P = 0.003). This survival disadvantage was independent of baseline clinical characteristics. Gene ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and GSEA showed that the differentially expressed genes between patients with high and low mRNAsi values were mainly enriched in oncogenic and metabolic pathways. Weighted gene coexpression network analysis (WGCNA) revealed 8 independent gene modules that were significantly associated with mRNAsi and 12 metabolic pathways. Unsupervised clustering based on the key genes in each module identified two PDAC subgroups characterized by different mRNAsi values and metabolic activities. Univariate Cox regression analysis identified 14 genes beneficial to OS from 95 key genes selected from the eight independent gene modules from WGCNA. Among them, MAGEH1, MAP3K3, and PODN were downregulated in both pancreatic tissues and cell lines. CONCLUSION: The present study showed that PDAC samples with high mRNAsi values exhibited aberrant activation of multiple metabolic pathways, and the patients from whom these samples were obtained had a poor prognosis. Future studies are expected to investigate the underlying mechanism based on the crosstalk between PDAC stemness and metabolic rewiring.
format Online
Article
Text
id pubmed-8071957
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80719572021-04-27 Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma Tang, Rong Liu, Xiaomeng Wang, Wei Hua, Jie Xu, Jin Liang, Chen Meng, Qingcai Liu, Jiang Zhang, Bo Yu, Xianjun Shi, Si Front Oncol Oncology BACKGROUND: Cancer stem cells (CSCs) are widely thought to contribute to the dismal prognosis of pancreatic ductal adenocarcinoma (PDAC). CSCs share biological features with adult stem cells, such as longevity, self-renewal capacity, differentiation, drug resistance, and the requirement for a niche; these features play a decisive role in cancer progression. A prominent characteristic of PDAC is metabolic reprogramming, which provides sufficient nutrients to support rapid tumor cell growth. However, whether PDAC stemness is correlated with metabolic reprogramming remains unknown. METHOD: RNA sequencing data of PDAC, including read counts and fragments per kilobase of transcript per million mapped reads (FPKM), were collected from The Cancer Genome Atlas-Pancreatic Adenocarcinoma (TCGA-PAAD) database. Single-sample gene set enrichment analysis (GSEA) was used to calculate the relative activities of metabolic pathways in each PDAC sample. Quantitative real-time PCR was performed to validate the expression levels of genes of interest. RESULTS: The overall survival (OS) of patients with high mRNA expression-based stemness index (mRNAsi) values was significantly worse than that of their counterparts with low mRNAsi values (P = 0.003). This survival disadvantage was independent of baseline clinical characteristics. Gene ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and GSEA showed that the differentially expressed genes between patients with high and low mRNAsi values were mainly enriched in oncogenic and metabolic pathways. Weighted gene coexpression network analysis (WGCNA) revealed 8 independent gene modules that were significantly associated with mRNAsi and 12 metabolic pathways. Unsupervised clustering based on the key genes in each module identified two PDAC subgroups characterized by different mRNAsi values and metabolic activities. Univariate Cox regression analysis identified 14 genes beneficial to OS from 95 key genes selected from the eight independent gene modules from WGCNA. Among them, MAGEH1, MAP3K3, and PODN were downregulated in both pancreatic tissues and cell lines. CONCLUSION: The present study showed that PDAC samples with high mRNAsi values exhibited aberrant activation of multiple metabolic pathways, and the patients from whom these samples were obtained had a poor prognosis. Future studies are expected to investigate the underlying mechanism based on the crosstalk between PDAC stemness and metabolic rewiring. Frontiers Media S.A. 2021-04-12 /pmc/articles/PMC8071957/ /pubmed/33912458 http://dx.doi.org/10.3389/fonc.2021.643465 Text en Copyright © 2021 Tang, Liu, Wang, Hua, Xu, Liang, Meng, Liu, Zhang, Yu and Shi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Tang, Rong
Liu, Xiaomeng
Wang, Wei
Hua, Jie
Xu, Jin
Liang, Chen
Meng, Qingcai
Liu, Jiang
Zhang, Bo
Yu, Xianjun
Shi, Si
Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma
title Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma
title_full Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma
title_fullStr Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma
title_full_unstemmed Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma
title_short Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma
title_sort identification of the roles of a stemness index based on mrna expression in the prognosis and metabolic reprograming of pancreatic ductal adenocarcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071957/
https://www.ncbi.nlm.nih.gov/pubmed/33912458
http://dx.doi.org/10.3389/fonc.2021.643465
work_keys_str_mv AT tangrong identificationoftherolesofastemnessindexbasedonmrnaexpressionintheprognosisandmetabolicreprogramingofpancreaticductaladenocarcinoma
AT liuxiaomeng identificationoftherolesofastemnessindexbasedonmrnaexpressionintheprognosisandmetabolicreprogramingofpancreaticductaladenocarcinoma
AT wangwei identificationoftherolesofastemnessindexbasedonmrnaexpressionintheprognosisandmetabolicreprogramingofpancreaticductaladenocarcinoma
AT huajie identificationoftherolesofastemnessindexbasedonmrnaexpressionintheprognosisandmetabolicreprogramingofpancreaticductaladenocarcinoma
AT xujin identificationoftherolesofastemnessindexbasedonmrnaexpressionintheprognosisandmetabolicreprogramingofpancreaticductaladenocarcinoma
AT liangchen identificationoftherolesofastemnessindexbasedonmrnaexpressionintheprognosisandmetabolicreprogramingofpancreaticductaladenocarcinoma
AT mengqingcai identificationoftherolesofastemnessindexbasedonmrnaexpressionintheprognosisandmetabolicreprogramingofpancreaticductaladenocarcinoma
AT liujiang identificationoftherolesofastemnessindexbasedonmrnaexpressionintheprognosisandmetabolicreprogramingofpancreaticductaladenocarcinoma
AT zhangbo identificationoftherolesofastemnessindexbasedonmrnaexpressionintheprognosisandmetabolicreprogramingofpancreaticductaladenocarcinoma
AT yuxianjun identificationoftherolesofastemnessindexbasedonmrnaexpressionintheprognosisandmetabolicreprogramingofpancreaticductaladenocarcinoma
AT shisi identificationoftherolesofastemnessindexbasedonmrnaexpressionintheprognosisandmetabolicreprogramingofpancreaticductaladenocarcinoma